Surgical Outcomes After Neoadjuvant Chemoimmunotherapy for Resectable Non-Small Cell Lung Cancer

Surgical Outcomes After Neoadjuvant Chemoimmunotherapy for Resectable Non-Small Cell Lung Cancer

BackgroundNeoadjuvant chemoimmunotherapy for resectable non-small cell lung cancer (NSCLC) represents an important research topic. Despite the potential benefits of this approach, the inflammatory responses and adverse events associated with neoadjuvant chemoimmunotherapy can present technical chall...

Full description

Bibliographic Details
Main Authors: Yan Hu, Si-Ying Ren, Ruo-Yao Wang, Chao Zeng, Ji-Na Li, Peng Xiao, Fang Wu, Feng-Lei Yu, Wen-Liang Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Oncology
Subjects:
neoadjuvant therapy
immunotherapy
immune checkpoint inhibitors
chemoimmunotherapy
surgery
non-small cell lung cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.684070/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.684070/full

Similar Items